Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade A 27.0 0.60% 0.16
HZNP closed up 0.6 percent on Friday, August 16, 2019, on 69 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical HZNP trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
Stochastic Reached Overbought Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
NR7 Range Contraction 0.60%
Inside Day Range Contraction 0.60%
Up 3 Days in a Row Strength 0.60%
Stochastic Sell Signal Bearish 1.66%
Upper Bollinger Band Walk Strength 1.66%

Older signals for HZNP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Asthma Osteoarthritis Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology Psoriatic Arthritis
Is HZNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.44
52 Week Low 16.56
Average Volume 2,142,178
200-Day Moving Average 23.6609
50-Day Moving Average 24.4324
20-Day Moving Average 25.2745
10-Day Moving Average 26.123
Average True Range 0.9372
ADX 19.63
+DI 30.7887
-DI 17.1176
Chandelier Exit (Long, 3 ATRs ) 24.9084
Chandelier Exit (Short, 3 ATRs ) 25.6516
Upper Bollinger Band 27.9712
Lower Bollinger Band 22.5778
Percent B (%b) 0.82
BandWidth 21.339295
MACD Line 0.728
MACD Signal Line 0.5269
MACD Histogram 0.2011
Fundamentals Value
Market Cap 4.41 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -10.00
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.01
Resistance 3 (R3) 28.07 27.79 27.84
Resistance 2 (R2) 27.79 27.54 27.76 27.78
Resistance 1 (R1) 27.40 27.38 27.60 27.34 27.73
Pivot Point 27.12 27.12 27.22 27.09 27.12
Support 1 (S1) 26.73 26.87 26.93 26.67 26.27
Support 2 (S2) 26.45 26.71 26.42 26.22
Support 3 (S3) 26.06 26.45 26.16
Support 4 (S4) 26.00